Provided by Tiger Fintech (Singapore) Pte. Ltd.

Veru Inc.

4.11
-0.0600-1.44%
Post-market: 4.190.0800+1.95%18:38 EDT
Volume:122.97K
Turnover:502.24K
Market Cap:60.21M
PE:-1.84
High:4.30
Open:4.15
Low:4.01
Close:4.17
52wk High:14.20
52wk Low:2.64
Shares:14.65M
Float Shares:12.58M
Volume Ratio:0.75
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2335
EPS(LYR):-2.8027
ROE:-106.02%
ROA:-52.13%
PB:3.92
PE(LYR):-1.47

Loading ...

Veru Inc. Unveils New Presentation Highlighting Obesity Drug Pipeline and Muscle Preservation Strategy

Reuters
·
Oct 17

Trump Excludes Generics From Big Pharma Tariff Plan

Dow Jones
·
Oct 09

Veru Inc.'s (NASDAQ:VERU) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Simply Wall St.
·
Oct 08

Veru Inc. Settles $8.8 Million Debt with Onconetix Through Cash, Preferred Stock, and Warrants Under Amended Loan Agreement

Reuters
·
Sep 26

Veru announces FDA meeting providing regulatory clarity for Enobosarm

TIPRANKS
·
Sep 23

Veru Inc - Clinical Study Expected to Begin in Q1 2026

THOMSON REUTERS
·
Sep 23

Veru Inc - FDA Confirms Enobosarm 3Mg as Acceptable Dosage

THOMSON REUTERS
·
Sep 23

Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity

GlobeNewswire
·
Sep 23

U.S. RESEARCH ROUNDUP-ANI Pharmaceuticals, Berkshire Hathaway, Chevron

Reuters
·
Aug 18

Veru Inc : Jefferies Cuts Target Price to $4 From $10

THOMSON REUTERS
·
Aug 18

Veru Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 12

Veru Inc. Announces 1-for-10 Reverse Stock Split to Regain Nasdaq Compliance

Reuters
·
Aug 12

Veru Q3 EPS $(0.50) Versus $(0.71) Prior Year

Benzinga
·
Aug 12

Veru Inc Qtrly Loss per Share $0.50

THOMSON REUTERS
·
Aug 12

Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress

GlobeNewswire
·
Aug 12

Veru Announces Selection of Novel Modified Release Oral Enobosarm Formulation for Chronic Weight Loss Management Following Pharmacokinetic Clinical Study

GlobeNewswire
·
Aug 11

Veru Inc expected to post a loss of 5 cents a share - Earnings Preview

Reuters
·
Aug 09

Veru Announces Reverse Stock Split

GlobeNewswire
·
Aug 06

Veru to Report Fiscal 2025 Third Quarter Financial Results on August 12th

GlobeNewswire
·
Aug 05

Veru Inc expected to post a loss of 5 cents a share - Earnings Preview

Reuters
·
Aug 04